Clinical Trial Update: A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing LDL-cholesterol lowering with Inclisiran versus Bempedoic acid in patients with atherosclerotic cardiovascular disease; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia

Drugs mentioned

• Bempedoic Acid (bempedoic acid)
• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED